# A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents

> **NCT00556998** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 26 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** Voriconazole

## Key facts

- **NCT ID:** NCT00556998
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2016-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00556998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00556998, "A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents". Retrieved via MORVS 2026-10-24 from https://api.morvs.ai/clinical/NCT00556998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*